inotuzumab,blinatumomab
amgen,pfizer,ucb pharmaceuticals,astellas
['leukemia', 'blinatumomab', 'inotuzumab']
congress | #ash22 | poster
ibrahim aldoss, presented a retrospective study on outcomes of pts with r/r b-all treated with blinatumomab, inotuzumab, or car-t. all 3 therapies were shown to be highly effective with cr rates of over 60% and up to 90%.
#allsm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm